Advanced Search


Study ID Status Title Patient Level Data
SAM108037 Terminated See Detailed Description
SAM30001 Completed Compliance in asthma and COPD treatment.
SAM30002 Completed A randomised, multi-centre, double blind, double-dummy, parallel-group comparison of Seretide RPID (50/100g strength) bd with budesonide BADPI 400g bd in steroid experienced adolescents and adults with reversible airways obstruction.
SAM30003 Completed A multicentre, randomised , open-label, parallel group comparison of Seretide Accuhaler TM bd with salmeterol 50mg twice daily via one Accuhaler and either fluticasone propionate 250mg or 500mg twice daily via a separate Accuhaler in adults with reversible airways disease.
SAM30007 Completed A multicentre, randomised, double-blind, controlled, parallel-group, comparative investigation of the corticosteroid-saving potential of the combination therapy fluticasone propionate and salmeterol compared with fluticasone propionate alone, given to adult asthmatic subjects, when reducing…
SAM30008 Completed A multi-centre, randomized, open-label, parallel-group, comparison study of the salmeterol/fluticasone propionate combination product via one Diskus/Accuhaler inhaler with salmeterol via one Diskus/Accuhaler inhaler and fluticasone propionate via another Diskus/Accuhaler inhaler in adults with ...
SAM30010 Completed A Randomized, Single-centre, Double-blind, Parallel-group Comparison of Seretide Accuhaler (50/250 µg Strength) bd with Fluticasone Accuhaler 250 µg bd in Subjects with Reversible Airways Obstruction
SAM30012 Completed An open study to assess the efficacy and safety of Seretide Diskus (salmeterol/fluticasone propionate 50/500mg strength) bd in subjects with reversible airways obstruction
SAM30013 Completed A 12 week, randomized, double-blind, parallel group study to compare the efficacy and safety of salmeterol/fluticasone propionate/GR106642X (25/50 µg x 2 inhalations) bid with fluticasone propionate (125 µg x 2 inhalations) bid in adolescent and adult patients with mild to moderate asthma.
SAM30020 Completed Efficacy and tolerability of the salmeterol/fluticasone 50/100 mcg combination Diskus, inhaled once daily in the evening, in comparison to the p.r.n. inhalation from the reproterol/sodium cromoglycate 0.5/ 1 mg combination MDI, as initial therapy for patients with mild asthma – a multicentre, ra ...
SAM30021 Completed A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125mg/actuation, bd) via a hydrofluoroalkane metered-doseinhaler compared…
SAM30022 Completed A phase IV, multi-centre, double-blind, double-dummy, parallel group, randomised study comparing Seretide (25/50 2 puffs bd) via the Evohaler (MDI-HFA) with Beclometasone dipropionate (200mcg 2 puffs bd) via the MDI-CFC in adolescents and adults experiencing moderate symptoms of reversible airwa ...
SAM3802 Completed An observational study to assess the health related quality of life impact of treating poorly controlled asthmatic children with Seretide 50/100mcg
SAM40004 Completed A multi-centre, randomised, double-blind, placebo-controlled parallel group study to compare the effect on airway inflammation and remodeling of treatment with salmeterol/fluticasone propionate combination product (50/100mg strength) bd via the Accuhaler inhaler, or fluticasone propionate…
SAM40008 Completed A Multicentre, Randomised, Double-Blind, Parallel Group Comparison of the Efficacy of SERETIDE* bd and Fluticasone Propionate bd (Both Via DISKUS*/ACCUHALER*, Inhaler) when Tapering the Inhaled Corticosteroid Dose in Asthmatic Adults Study Listed on
SAM40010 Completed A randomised, double blind, double-dummy, parallel-group, twelve week comparison of salmeterol/fluticasone propionate (FP) DISKUS/ACCUHALER 50/100mcg bd. with budesonide 200mcg bd. plus formoterol 4.5mcg bd. (both via breath-actuated dry powder inhaler [BADPI]) in Adult and Adolescent Asthmatics.
SAM40012 Completed A multicentre, randomised, double-blind, double-dummy, parallel group comparison of three treatments : 1) salmeterol/fluticasone propionate (SFC) 50/100mcg strength) bd via DISKUS/ACCUHALER inhaler, 2) fluticasone propionate 200mcg bd via DISKUS/ACCUHALER inhaler, 3) fluticasone propionate 100mcg bd via DISKUS/ACCUHALER inhaler in children aged 4- 11 years with asthma Study Listed on
SAM40023 Completed A 6 week randomized, double-blind, parallel group study to compare efficacy of fluticasone propionate 250mcg BID, salmeterol 50mcg BID and fluticasone propionate 250mcg plus salmeterol 50 mcg BID for the treatment of nocturnal airway obstruction.
SAM40027 Completed A Multicentre, stratified, randomised, double-blind, parallel-group, step-up comparison of the level of asthma control achieved with salmeterol/fluticasone propionate combination diskus (Accuhaler) dry powder inhaler compared with fluticasone propionate Diskus alone in adults and adolescents. Study Listed on
SAM40030 Completed A phase IV, multicentre, randomised, double blind, single dummy, parallel group study to compare the anti-inflammatory action of Seretide 50/100 bd via MDI with Flixotide 100mg bd via MDI plus montelukast 10mg od for 12 weeks in adults with mild to moderate asthma who are currently taking…
SAM40031 Completed A 13 month, randomised, double-blind, parallel-group comparison of the efficacy of Seretide and Flixotide(fluticasone propionate Accuhaler) when down-titrating the inhaled corticosteroid dose in asthmatic adults who have previously received SeretideTM 500/50 mg twice daily for at least 4 weeks. Study Listed on
SAM40032 Completed A multi-centre, open label study to demonstrate the efficacy and tolerability of Seretide Accuhaler 50/100, 50/250 or 50/500mg twice daily after substituting for budesonide or beclomethasone dipropionate in doses of 500mg up to 2000mg daily in subjects with reversible airways obstruction.
SAM40034 Completed A double-blind, randomised, parallel group, 12-week comparison of fluticasone propionate/salmeterol combination Diskus 100/50mcg BID with fluticasone propionate (FP) 250mcg BID as initial maintenance treatment in persistent asthma (Seretide Nordic Jump-Up Study)
SAM40036 Completed A 12-week multicentre, randomised, double-blind, double-dummy, parallel group study to compare the efficacy and tolerability of once daily salmeterol/fluticasone propionate combination (salm/FP) 50/100mcg at night via the DISKUS/ACCUHALER with once daily budesonide (BUD) 400mcg at night via a breath-actuated dry powder inhaler (BADPI) as initial maintenance therapy in mild-to-moderate asthmatic subjects Study Listed on
SAM40040 Completed A 24-week, randomsed, double dummy, double blind, parallel group study to compare the occurence of exacerbations between Seretide Diskus 50/250 bd and Symbicort BADPI (Turbuhaler) 4.5/160 two inhalations bd in subjects with moderate to severe asthma Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.